COMPANIES COVERED
BioMerieuxDownload FREE Report Sample
Download Free sampleSexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles.
Sexually Transmitted Diseases Testing Market contains market size and forecasts of Sexually Transmitted Diseases Testing in Global, including the following market information:
Global Sexually Transmitted Diseases Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sexually Transmitted Diseases Testing market was valued at 76560 million in 2021 and is projected to reach US$ 102850 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chlamydia Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Diseases Testing include BioMerieux, F. Hoffmann La Roche, BD, Abbott, Bio-Rad Laboratories, Abbott and Qiagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sexually Transmitted Diseases Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Diseases Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Diseases Testing Market Segment Percentages, by Type, 2021 (%)
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other
Global Sexually Transmitted Diseases Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Diseases Testing Market Segment Percentages, by Application, 2021 (%)
Clinics
Hospitals
Other
Global Sexually Transmitted Diseases Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sexually Transmitted Diseases Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Diseases Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sexually Transmitted Diseases Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioMerieux
F. Hoffmann La Roche
BD
Abbott
Bio-Rad Laboratories
Abbott
Qiagen
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
